Patents by Inventor Peter Jenner

Peter Jenner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment for neurodegeneration
    Patent number: 7790687
    Abstract: Polypeptides which are an N- and/or C-terminally truncated fragment of the human osteopontin (hOPN) sequence or species variant, and which minimally have a 15 amino acid sequence corresponding to amino acids 138 to 152 of hOPN, and polynucleotides encoding said polypeptide, are useful for treatment or prevention of neurodegeneration.
    Type: Grant
    Filed: February 17, 2006
    Date of Patent: September 7, 2010
    Assignee: Proximagen Ltd.
    Inventors: Joanna Iczkiewicz, Peter Jenner
  • Treatment for Neurodegeneration
    Publication number: 20090137463
    Abstract: Polypeptides which are an N- and/or C-terminally truncated fragment of the human osteopontin (hOPN) sequence or species variant, and which minimally have a 15 amino acid sequence corresponding to amino acids 138 to 152 of hOPN, and polynucleotides encoding said polypeptide, are useful for treatment or prevention of neurodegeneration.
    Type: Application
    Filed: February 17, 2006
    Publication date: May 28, 2009
    Inventors: Joanna Iczkiewicz, Peter Jenner
  • Inhibition or Treatment of Dyskinesia
    Publication number: 20080070952
    Abstract: Prevention or treatment of dyskinesia induced by L-dopa or dopamine agonist can be effected by use of a selective inhibitor of neuronal nitric oxide synthase.
    Type: Application
    Filed: February 20, 2006
    Publication date: March 20, 2008
    Applicant: PROXIMAGEN LTD.,
    Inventors: Mahmoud Irvani, Peter Jenner
  • Treatment
    Publication number: 20060264371
    Abstract: The invention provides a method of treating or preventing neurodegeneration in a subject in need thereof, which method comprises the step of administering to the subject a therapeutically effective amount of a polypeptide, or a polynucleotide encoding said polypeptide, wherein said polypeptide has the amino acid sequence shown in SEQ ID NO: 2, or an amino acid sequence having at least 90% homology to the amino acid sequence shown in SEQ ID NO: 2.
    Type: Application
    Filed: February 17, 2006
    Publication date: November 23, 2006
    Applicant: Proximagen Ltd.
    Inventors: Peter Jenner, Joanna Iczkiewicz
  • Use of N-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulphamoyl benzamide in the treatment of Parkinson's disease
    Patent number: 4725618
    Abstract: The use of N-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulphamoyl benzamide to treat Parkinson's disease.
    Type: Grant
    Filed: July 15, 1986
    Date of Patent: February 16, 1988
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventors: Denis Besancon, Brenda Costall, Robert J. Naylor, Peter Jenner, Charles D. Marsden